These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 33992536)
1. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy. Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536 [TBL] [Abstract][Full Text] [Related]
2. Poor Outcomes Related to Anterior Extension of Large Hemispheric Infarction: Topographic Analysis of GAMES-RP Trial MRI Scans. Payabvash S; Falcone GJ; Sze GK; Jain A; Beslow LA; Petersen NH; Sheth KN; Kimberly WT J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104488. PubMed ID: 31787498 [TBL] [Abstract][Full Text] [Related]
4. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke). Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial. Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934 [TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke. Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177 [TBL] [Abstract][Full Text] [Related]
7. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial. de Celis-Ruiz E; Fuentes B; Alonso de Leciñana M; Gutiérrez-Fernández M; Borobia AM; Gutiérrez-Zúñiga R; Ruiz-Ares G; Otero-Ortega L; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E Cell Transplant; 2022; 31():9636897221083863. PubMed ID: 35301883 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of GABA Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM; Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Chung JW; Chang WH; Bang OY; Moon GJ; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH; Neurology; 2021 Feb; 96(7):e1012-e1023. PubMed ID: 33472925 [TBL] [Abstract][Full Text] [Related]
11. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke. Felberg RA; Okon NJ; El-Mitwalli A; Burgin WS; Grotta JC; Alexandrov AV Stroke; 2002 May; 33(5):1301-7. PubMed ID: 11988607 [TBL] [Abstract][Full Text] [Related]
12. Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome in Patients with Large Vessel Occlusion and Mild Symptoms. Kimmel ER; Al Kasab S; Harvey JB; Bathla G; Ortega-Gutierrez S; Toth G; Jaksich EM; Sheharyar A; Roa J; Hasan DM; Samaniego EA J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1987-1992. PubMed ID: 31036341 [TBL] [Abstract][Full Text] [Related]
13. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Prasad K; Mohanty S; Bhatia R; Srivastava MV; Garg A; Srivastava A; Goyal V; Tripathi M; Kumar A; Bal C; Vij A; Mishra NK Indian J Med Res; 2012 Aug; 136(2):221-8. PubMed ID: 22960888 [TBL] [Abstract][Full Text] [Related]
14. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723 [TBL] [Abstract][Full Text] [Related]
15. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313 [TBL] [Abstract][Full Text] [Related]
16. Clinical diffusion mismatch better discriminates infarct growth than mean transit time-diffusion weighted imaging mismatch in patients with middle cerebral artery-M1 occlusion and limited infarct core. Nogueira RG; Kemmling A; Souza LM; Payabvash S; Hirsch JA; Yoo AJ; Lev MH J Neurointerv Surg; 2017 Feb; 9(2):127-130. PubMed ID: 26957483 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635 [TBL] [Abstract][Full Text] [Related]
18. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial. Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O; Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427 [TBL] [Abstract][Full Text] [Related]
19. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial. Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701 [TBL] [Abstract][Full Text] [Related]